Outcomes of Treatment for Melanoma Brain Metastases

Table 5

Survival results depending on the number of the metastases.

Group	Number of patients	1-year survival	2-year survival	5-year survival
Solitary CNS metastases	13 (26%)	85.6% [51.8; 96.2]	69.2% [37.3; 87.2]	43.1% [15.6; 68.3]
Multiple CNS metastases	37 (74%)	78.4% [61.4; 88.6]	48.7% [32.0; 63.4]	13.4% [4.5; 27.2]